Skip to content

    BridgeBio Pharma (BBIO) stock price & financials

    View BBIO earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+54.5% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $2.73M
    $5.88M
    $116.63M
    $110.56M
    $120.70M
    +4318.0%
    $154.18M
    +2521.2%
    $194.51M
    +66.8%
    $243.68M
    +120.4%
    Strengthening
    Operating Profit
    -$191.75M
    -$226.03M
    -$104.37M
    -$134.28M
    -$145.20M
    +24.3%
    -$139.56M
    +38.3%
    -$105.96M
    -1.5%
    -$107.08M
    +20.3%
    Strengthening
    Net Profit
    EPS
    $-0.86
    $-0.88
    $-0.95
    $-0.95
    -10.5%
    $-0.84
    +4.5%
    $-0.78
    +17.9%
    Strengthening
    Other Income
    $27.50M
    -$40.21M
    -$65.24M
    -$47.38M
    -$41.28M
    -250.1%
    -$55.19M
    -37.3%
    -$60.60M
    +7.1%
    -$48.81M
    -3.0%
    Weakening
    Interest
    $23.06M
    $21.52M
    $18.12M
    $11.61M
    $11.74M
    -49.1%
    $11.64M
    -45.9%
    $12.94M
    -28.6%
    $13.28M
    +14.4%
    Weakening
    Depreciation
    Profit before Tax
    -$164.25M
    -$181.66M
    -$186.48M
    -13.5%
    -$155.89M
    +14.2%
    Strengthening
    MarginsOPM
    -7018.7%
    -3842.7%
    -89.5%
    -121.5%
    -120.3%
    +98.3%
    -90.5%
    +97.6%
    -54.5%
    +39.1%
    -43.9%
    +63.8%
    Strengthening
    Tax
    0.0%
    -1.2%
    0.8%
    0.0%
    +100.0%
    Strengthening
    ReturnsROIC

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$436.09M$363.77M$356.08M$393.77M$376.69M$375.94M$681.10M$570.12M$677.91M
    Short-Term Investments$182.22M$251.01M$393.74M$51.58M$0$0
    Total Current Assets$445.22M$568.62M$642.82M$888.86M$548.85M$477.59M$720.69M$797.75M$1.09B
    Net PP&E$1.57M$15.63M$36.83M$45.97M$25.25M$19.84M$12.78M$13.52M$22.30M
    Goodwill
    Intangibles$0$44.93M$28.71M$26.32M$23.93M$28.08M$26.64M
    Total Assets$464.94M$631.68M$703.59M$1.01B$623.04M$546.38M$919.34M$936.02M$1.22B
    LiabilitiesTotal Current Liabilities$32.58M$60.38M$95.65M$135.07M$121.43M$143.84M$154.40M$287.97M$890.65M
    Short-Term Debt$1.46M
    Long-Term Debt$54.51M$91.79M$92.42M$430.75M$430.99M$446.44M$437.34M$2.01B$2.65B
    Long-Term Leases$14.68M$17.43M$12.27M$8.98M$4.70M$3.81M$14.97M
    Total Liabilities$87.58M$155.70M$595.70M$1.88B$1.87B$1.89B$2.38B$3.01B$3.72B
    EquityCommon Stock & APIC$92.0K$124.0K$125.0K$154.0K$157.0K$181.0K$196.0K$202.0K$206.0K
    Retained Earnings-$179.44M-$440.03M-$888.75M-$1.44B-$1.92B-$2.56B-$3.10B-$3.82B-$4.14B
    Total Equity$314.88M$408.45M$57.91M-$870.41M-$1.25B-$1.35B-$1.47B-$2.09B-$2.52B
    HighlightsNet Cash / (Debt)$513.21M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$136.64M-$253.59M-$399.71M-$497.93M-$419.49M-$527.72M-$520.73M-$445.91M-$434.37M
    Cash from Investing-$21.04M-$217.25M-$52.99M-$200.83M$453.15M$54.03M$60.78M-$24.49M-$34.74M
    Cash from Financing$501.55M$398.79M$447.19M$736.45M-$13.13M$451.54M$748.46M$359.29M$398.05M
    SummaryCapital Expenditure-$2.18M-$2.64M-$7.52M-$13.25M-$4.82M-$1.31M-$933.0K-$1.10M-$1.01M
    Free Cash Flow-$138.82M-$256.23M-$407.23M-$511.18M-$424.31M-$529.03M-$521.66M-$447.01M-$435.39M
    FCF Margin-631.7%-4936.7%-733.2%-546.5%-5686.6%-235.1%-89.0%-61.1%

    Ratios